Drug Shortage Report for ROCURONIUM BROMIDE INJECTION
Report ID | 242057 |
Drug Identification Number | 02469774 |
Brand name | ROCURONIUM BROMIDE INJECTION |
Common or Proper name | Rocuronium Bromide Injection |
Company Name | JUNO PHARMACEUTICALS CORP. |
Market Status | MARKETED |
Active Ingredient(s) | ROCURONIUM BROMIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 mL (10 mg/mL) x 10 vials |
ATC code | M03AC |
ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-11-04 |
Actual start date | 2024-11-04 |
Estimated end date | 2025-01-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-25 |
Company comments | (L) 40903A |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2233 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 2X7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-11-25 | French | Compare |
v6 | 2024-11-25 | English | Compare |
v5 | 2024-11-14 | French | Compare |
v4 | 2024-11-14 | English | Compare |
v3 | 2024-11-05 | English | Compare |
v2 | 2024-11-04 | French | Compare |
v1 | 2024-11-04 | English | Compare |
Showing 1 to 7 of 7